Skip to main content
Clinical Trials/NCT03470974
NCT03470974UnknownNot Applicable

National Defense Medical Center

Tri-Service General Hospital1 site in 1 country222 target enrollmentStarted: February 3, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
222
Locations
1
Primary Endpoint
evaluate the effects of self-titration strategy on the improvement of home blood pressure

Study Overview

Brief Summary

This study aims to investigate the relationship among self-efficacy, anxiety, depressive symptoms, quality of life, lifestyle, heart rate variability and blood pressure control; and to examine the effects of self-titration strategy on self-efficacy, anxiety, depressive symptoms,heart rate variability, sodium excretion, lifestyle modification,quality of life, and blood pressure control in patients with hypertension.

Detailed Description

Background: Hypertension is the major cause of mortality for the cardiac, vascular and renal disease. The effective control of elevated blood pressure may reduce the damages of several target organs. World Health Organization points out "Innovation and Empowerment for health". The self-titration strategy may empower patients to self-control their diseases, share decision-making and increase their ability to self-management their situations and improve their home blood pressure.

Methods: This experimental study included 222 hypertensive patients from outpatient services of cardiology departments of a medical center in northern Taiwan. We randomly divided the 72 patients into the experimental group (n=111) and control group (n=111). The experimental group received self-titration strategy training and lifestyle modification education; the control group received usual care and lifestyle modification education.

Data were collected for self-efficacy, anxiety symptoms, depressive symptoms, lifestyle and health-related quality of life using self-report questionnaires. Heart rate variability was measured with CheckMyHeart device (DailyCare BioMedical, Chungli, Taiwan). Patients evaluated their home blood pressure by corrected sphygmomanometer. We used the generalized estimating equation to evaluate the effects of the intervention.

Purpose: Primary outcome to evaluate the effects of self-titration strategy on the improvement of home blood pressure in patients with hypertension. Secondary outcomes to evaluate the effects of self-titration strategy on the improvement of self-efficacy, anxiety, depressive symptoms and lifestyle quality of life in patients with hypertension.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 79 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •≥ 20 years old.
  • •diagnosed with primary hypertension.
  • •no addiction to drugs or alcohol.
  • •not using anti-depression therapy.
  • •able to read and understand Chinese or Taiwanese.
  • •willing to participate in this study.

Exclusion Criteria

  • •arrhythmia.
  • •major psychiatric disorders
  • •thyroid disease.
  • •had received a heart transplant, a permanent pacemaker or an implantable cardioverter defibrillator, diagnosed with (6) cancer, (7) heart failure, or (8) acute myocardial infarction.

Arms & Interventions

Intervention Group

Experimental

The intervention group receives self-titration strategy training and lifestyle education.

Intervention: Self-titration strategy (Behavioral)

Control Group

No Intervention

The control group receives usual care and lifestyle education.

Outcomes

Primary Outcomes

evaluate the effects of self-titration strategy on the improvement of home blood pressure

Time Frame: up to 3 months

Patients evaluated their home blood pressure by corrected sphygmomanometer.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fung-Wei Chang

Director, Head of Obstetrics and Gynecology

Tri-Service General Hospital

Study Sites (1)

Loading locations...

Similar Trials